Basics Relmada Therapeutics, Inc. IPO Date: June 16, 2014 Sector: Healthcare Industry: Biotech Market Cap: $23.52M Activated in VL: True Average Daily Range Avg Daily Range: $0.56 | 3.71% Avg Daily Range (30 D): $0.05 | 10.44% Avg Daily Range (90 D): $0.04 | 8.64% Institutional Daily Volume Avg Daily Volume: .31M Avg Daily Volume (30 D): 1.37M Avg Daily Volume (90 D): 1.39M Trade Size Avg Trade Size (Sh.): 133 Avg Trade Size (Sh.) (30 D): 560 Avg Trade Size (Sh.) (90 D): 576 Institutional Trades Total Inst.Trades: 365 Avg Inst. Trade: $2.13M Avg Inst. Trade (30 D): $.6M Avg Inst. Trade (90 D): $.6M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.27M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 102.03K     News Apr 28, 2025 @ 5:38 PM Relmada Therapeutics Presents Positive Initial Pha... Source: N/A Apr 27, 2025 @ 1:00 PM UPDATE -- Relmada Therapeutics To Present NDV-01 D... Source: N/A Feb 25, 2025 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Dec 9, 2024 @ 12:30 PM Relmada Therapeutics to Discontinue the Reliance I... Source: Globe Newswire Feb 1, 2024 @ 1:42 PM Relmada Therapeutics And 2 Other Penny Stocks Insi... Source: Avi Kapoor Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.51 $-.58 $-.62 Diluted EPS $-2.51 $-.58 $-.62 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -75.71M $ -17.56M $ -18.66M Operating Income / Loss $ -79.12M $ -18.22M $ -19.08M Cost of Revenue $ $ $ Net Cash Flow $ 2.52M $ M $ 2.37M PE Ratio     Splits Sep 30, 2019:   1:4 Aug 12, 2015:   1:5